{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T12:20:34Z","timestamp":1785154834842,"version":"3.55.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T00:00:00Z","timestamp":1539648000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Model"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00894-018-3838-x","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T06:04:35Z","timestamp":1539669875000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pharmacophore modeling, docking and molecular dynamics to identify Leishmania major farnesyl pyrophosphate synthase inhibitors"],"prefix":"10.1007","volume":"24","author":[{"given":"Larissa","family":"de Mattos Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janay Stefany Carneiro","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bacelar Costa Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isis Bugia","family":"Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Am\u00e2ncio","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco Henrique Andrade","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel Guimar\u00e3es","family":"Benevides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3271-3529","authenticated-orcid":false,"given":"Manoelito","family":"Coelho dos Santos Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,16]]},"reference":[{"key":"3838_CR1","first-page":"3621","volume":"10","author":"JLP P\u00e9rez-Arellano","year":"2010","unstructured":"P\u00e9rez-Arellano JLP, Carranza-Rodriguez C, Cordero-S\u00e1nchez M, Muro A (2010) Infecciones por protozoos hemoflagelados I: Leishmaniosis. Medicine 10:3621\u20133631","journal-title":"Medicine"},{"key":"3838_CR2","unstructured":"World Health Organization (2013) World: Endemicity of cutaneous leishmaniasis, WHO Leishmaniasis control programme. Annual country reports. http:\/\/www.who.int\/leishmaniasis\/en\/"},{"key":"3838_CR3","unstructured":"World Health Organization (2017) Integrating neglected tropical diseases into global health and development: fourth WHO report on neglected tropical diseases. World Health Organization, Geneva"},{"key":"3838_CR4","unstructured":"World Health Organization (2010) Control of the leishmaniasis: report of a meeting of the WHO Expert Committee on the Control of Leishmaniases, World Health Organization, Geneva"},{"key":"3838_CR5","unstructured":"Pan American Health Organization (2017) Informe de Leishmanioses n\u00b0 5, LEISHMANIOSES Informe Epidemiol\u00f3gico das Am\u00e9ricas. http:\/\/iris.paho.org\/xmlui\/handle\/123456789\/34857"},{"key":"3838_CR6","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","volume":"354","author":"BL Herwaldt","year":"1999","unstructured":"Herwaldt BL (1999) Leishmaniasis. Lancet 354:1191\u20131199","journal-title":"Lancet"},{"key":"3838_CR7","volume-title":"Patologia: bases clinicopatol\u00f3gicas da medicina","author":"E Rubin","year":"2006","unstructured":"Rubin E, Gorstein F, Schwarting R, Rubin R, Strayer D (2006) Patologia: bases clinicopatol\u00f3gicas da medicina. Guanabara Koogan, Rio de Janeiro"},{"key":"3838_CR8","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1051\/medsci\/20132912020","volume":"29","author":"H Louzir","year":"2013","unstructured":"Louzir H, Aoun K, Sp\u00e4th GF, Laouini D, Prina E, Victoir K, Bouratbine A (2013) Les leishmanioses vues au travers du r\u00e9seau international des Instituts Pasteur. Med Sci (Paris) 29:1151\u20131160","journal-title":"Med Sci (Paris)"},{"key":"3838_CR9","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1590\/S0100-40422003000400018","volume":"26","author":"S Rath","year":"2003","unstructured":"Rath S, Trivelin LA, Imbrunito TR, Tomazela DM, Jes\u00fas MN, Marzal PC (2003) Antimoniais empregados no tratamento da Leishmaniose: estado da arte. Quim Nova 26:550\u2013555","journal-title":"Quim Nova"},{"key":"3838_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4103\/0974-777X.62887","volume":"2","author":"J Chakravarty","year":"2010","unstructured":"Chakravarty J, Sundar S (2010) Drug resistance in Leishmaniasis. J Global Infect Dis 2:167\u2013176","journal-title":"J Global Infect Dis"},{"key":"3838_CR11","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1371\/journal.pmed.0030162","volume":"3","author":"R Hadighi","year":"2006","unstructured":"Hadighi R, Mohebali M, Boucher P, Hajjaran H, Khamesipour A, Ouellette M (2006) Unresponsiveness to Glucantime treatment in Iranian cutaneous Leishmaniasis due to drug-resistant Leishmania tropica parasites. PLoS Med 3:659\u2013667","journal-title":"PLoS Med"},{"key":"3838_CR12","first-page":"70","volume":"34","author":"K Zaveri","year":"2015","unstructured":"Zaveri K, Chaitanya AK, Reddy IB (2015) Virtual screening and docking studies of identified potential drug target: polysaccharide deacetylase in Bacillus anthracis. Int Lett Nat Sci 34:70\u201377","journal-title":"Int Lett Nat Sci"},{"key":"3838_CR13","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/07391102.2011.10508589","volume":"28","author":"C-H Lin","year":"2011","unstructured":"Lin C-H, Chang T-T, Sun M-F, Chen H-Y, Tsai F-J, Chang K-L, Fisher M, Chen CY-C (2011) Potent inhibitor design against H1N1 swine influenza: structure-based and molecular dynamics analysis for M2 inhibitors from traditional Chinese medicine database. J Biomol Struct Dyn 28:471\u2013482","journal-title":"J Biomol Struct Dyn"},{"key":"3838_CR14","first-page":"173","volume-title":"Bioinform\u00e1tica da Biologia \u00e0 flexibilidade molecular","author":"H Verli","year":"2014","unstructured":"Verli H (2014) Din\u00e2mica Molecular. In: Verli H (ed) Bioinform\u00e1tica da Biologia \u00e0 flexibilidade molecular1st edn. SBBq, S\u00e3o Paulo, pp 173\u2013187","edition":"1"},{"key":"3838_CR15","unstructured":"Leite FHA (2011) Estudos de acoplamento molecular entre per\u00f3xidos obtidos de fontes naturais e o grupo heme. Dissertation, Universidade Estadual de Feira de Santana"},{"key":"3838_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrd4510","volume":"14","author":"AL Harvey","year":"2015","unstructured":"Harvey AL, Edrada-Ebel R, Quinn RJ (2015) The re-emergence of natural products for drug discovery in the genomics era. Nat Rev Drug Discov 14:11\u2013129","journal-title":"Nat Rev Drug Discov"},{"key":"3838_CR17","doi-asserted-by":"publisher","first-page":"33930","DOI":"10.1074\/jbc.M103950200","volume":"276","author":"A Montalvetti","year":"2001","unstructured":"Montalvetti A, Bailei BN, Martin MB, Severin GW, Oldfield E, Docampo R (2001) Bisphosphonates are potent inhibitors of Trypanosoma cruzi. J Biol Chem 276:33930\u201333937","journal-title":"J Biol Chem"},{"key":"3838_CR18","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ijantimicag.2003.07.019","volume":"23","author":"LR Garzoni","year":"2004","unstructured":"Garzoni LR, Waghabi MC, Baptista MM, Castro SL, Meirelles MN, Britto CC, Docampo R, Oldfield E, Urbina JA (2004) Antiparasitic activity of risedronate in a murine model of acute Chagas\u2019 disease. Int J Antimicrob Agents 23:286\u2013290","journal-title":"Int J Antimicrob Agents"},{"key":"3838_CR19","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ejmech.2012.12.015","volume":"60","author":"M Recher","year":"2013","unstructured":"Recher M, Barboza AP, Li ZH, Galizzi M, Ferrer-Casal M, Szajnman SH, Docampo R, Moreno SN, Rodriguez JB (2013) Design, synthesis and biological evaluation of sulfur-containing 1,1-bisphosphonic acids as antiparasitic agents. Eur J Med Chem 60:431\u2013440","journal-title":"Eur J Med Chem"},{"key":"3838_CR20","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.nbt.2012.07.001","volume":"30","author":"MK Dhar","year":"2013","unstructured":"Dhar MK, Koul A, Kaul S (2013) Farnesyl pyrophosphate synthase: a key enzyme in isoprenoid biosynthetic pathway and potential molecular target for drug development. New Biotechnol 30:114\u2013123","journal-title":"New Biotechnol"},{"key":"3838_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2009\/642502","volume":"2009","author":"W Souza","year":"2009","unstructured":"Souza W, Rodrigues JCF (2009) Sterol biosynthesis pathway as target for anti-trypanosomatid drugs. Interdiscip Perspect Infect Dis 2009:1\u201319","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"3838_CR22","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/prot.20754","volume":"62","author":"SB Gabelli","year":"2006","unstructured":"Gabelli SB, McLellan JS, Montalvetti A, Oldfield E, Docampo R, Amzel LM (2006) Structure and mechanism of the farnesyl diphosphate synthase from Trypanosoma cruzi: implications for drug design. Proteins: Struct Funct Bioinf 62:80\u201388","journal-title":"Proteins: Struct Funct Bioinf"},{"key":"3838_CR23","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.1021\/jm0302344","volume":"46","author":"JM Sanders","year":"2003","unstructured":"Sanders JM, G\u00f3mez AO, Mao J, Meints GA, Brussel EMV, Burzynska A, Kafarski P, Gonz\u00e1lez-Pacanowska D, Oldfield E (2003) 3-D QSAR investigations of the inhibition of Leishmania major farnesyl pyrophosphate synthase by bisphosphonates. J Med Chem 46:5171\u20135183","journal-title":"J Med Chem"},{"key":"3838_CR24","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1021\/jm040209d","volume":"48","author":"JM Sanders","year":"2005","unstructured":"Sanders JM, Song Y, Chan JMW, Zhang Y, Jennings S, Kosztowski T, Odeh S, Flessner R, Schwerdtfeger C, Kotsikorou E, Meints GA, G\u00f3mez AO, Gonz\u00e1lez-Pacanowska D, Raker AM, Wang H, Van Beek ER, Papapoulos SE, Morita CT, Oldfield E (2005) Pyridinium-1-yl bisphosphonates are potent inhibitors of farnesyl diphosphate synthase and bone resorption. J Med Chem 48:2957\u20132963","journal-title":"J Med Chem"},{"key":"3838_CR25","unstructured":"CHEMAXON (2013) MarvinSketch. version 5.12.1: ChemAxon"},{"key":"3838_CR26","unstructured":"TRIPOS (2011) GALAHAD Manual. SYBYL 2.0, p. 1\u201390, St Louis, MO"},{"key":"3838_CR27","doi-asserted-by":"publisher","first-page":"6582","DOI":"10.1021\/jm300687e","volume":"55","author":"MM Mysinger","year":"2012","unstructured":"Mysinger MM, Carchia M, Irwin JJ, Shoichet BK (2012) Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking. J Med Chem 55:6582\u20136594","journal-title":"J Med Chem"},{"key":"3838_CR28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The protein data Bank. Nucleic Acids Res 28:235\u2013242","journal-title":"Nucleic Acids Res"},{"key":"3838_CR29","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch G, Greenblatt DM, Meng EC, Ferrin TE (2004) UCSF chimera\u2014a visualization system for exploratory research and analysis. J Comput Chem 25:1605\u20131612","journal-title":"J Comput Chem"},{"key":"3838_CR30","doi-asserted-by":"publisher","first-page":"W665","DOI":"10.1093\/nar\/gkh381","volume":"32","author":"TJ Dolinsky","year":"2004","unstructured":"Dolinsky TJ, Nielsen JE, McCammon JA, Baker NA (2004) PDB2PQR: an automated pipeline for the setup, execution, and analysis of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res 32:W665\u2013W667","journal-title":"Nucleic Acids Res"},{"key":"3838_CR31","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1128\/EC.00034-06","volume":"5","author":"A Ortiz-G\u00f3mez","year":"2006","unstructured":"Ortiz-G\u00f3mez A, Jim\u00e9nez C, Est\u00e9vez AM, Carrero-L\u00e9rida J, Ruizp\u00e9rez LM, Gonz\u00e1lez-Pacanowska D (2006) Farnesyl diphosphate synthase is a cytosolic enzyme in Leishmania major promastigotes and its overexpression confers resistance to Risedronate. Eukaryot Cell 5:1057\u20131064","journal-title":"Eukaryot Cell"},{"key":"3838_CR32","unstructured":"Lang PT et al (2015) DOCK 6.7 users manual"},{"key":"3838_CR33","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455\u2013461","journal-title":"J Comput Chem"},{"key":"3838_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0263-7855(88)80054-7","volume":"6","author":"TE Ferrin","year":"1988","unstructured":"Ferrin TE, Huang CC, Jarvis LE, Langridge R (1988) The Midas display system. J Mol Graf 6:13\u201327","journal-title":"J Mol Graf"},{"key":"3838_CR35","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0022-2836(82)90153-X","volume":"161","author":"ID Kuntz","year":"1982","unstructured":"Kuntz ID, Blaney JM, Oatley SJ, Langridge R, Ferrin TE (1982) A geometric approach to macromolecule\u2013ligand interactions. J Mol Biol 161:269\u2013288","journal-title":"J Mol Biol"},{"key":"3838_CR36","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/jcc.540130311","volume":"13","author":"BK Shoichet","year":"1992","unstructured":"Shoichet BK, Kuntz ID, Bodian DL (1992) Molecular docking using shape descriptors. J Comput Chem 13:380\u2013397","journal-title":"J Comput Chem"},{"key":"3838_CR37","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/jcc.540130412","volume":"13","author":"EC Meng","year":"1992","unstructured":"Meng EC, Shoichet BK, Kuntz ID (1992) Automated docking with grid-based energy evaluation. J Comput Chem 13:505\u2013524","journal-title":"J Comput Chem"},{"key":"3838_CR38","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1021\/ar000033j","volume":"33","author":"PA Kollman","year":"2000","unstructured":"Kollman PA, Massova I, Reyes C, Kuhn B, Huo S, Chong L, Lee M, Lee T, Duan Y, Wang W, Donini O, Cieplak P, Srinivasan J, Case DA, Cheatham TE (2000) Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res 33:889\u2013897","journal-title":"Acc Chem Res"},{"key":"3838_CR39","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1021\/jp506555w","volume":"119","author":"L Jiang","year":"2015","unstructured":"Jiang L, Rizzo RC (2015) Pharmacophore-based similarity scoring for DOCK. J Phys Chem B 119:1083\u20131102","journal-title":"J Phys Chem B"},{"key":"3838_CR40","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"16","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) Autodock4 and AutoDockTools4: automated docking with selective receptor flexiblity. J Comput Chem 16:2785\u20132791","journal-title":"J Comput Chem"},{"key":"3838_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13321-015-0067-5","volume":"7","author":"WP Feinstein","year":"2015","unstructured":"Feinstein WP, Brylinski M (2015) Calculating an optimal box size for ligand docking and virtual screening against experimental and predicted binding pockets. J Cheminform 7:1\u201310","journal-title":"J Cheminform"},{"key":"3838_CR42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1\u20132","author":"MJ Abraham","year":"2015","unstructured":"Abraham MJ, Murtolad T, Schulzb R, P\u00e1lla S, Smithb JC, Hessa B, Lindahla E (2015) GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1\u20132:19\u201325","journal-title":"SoftwareX"},{"key":"3838_CR43","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey W, Dalke A, Schulten K (1996) VMD\u2014visual molecular dynamics. J Mol Graph 14:33\u201338","journal-title":"J Mol Graph"},{"key":"3838_CR44","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","volume":"55","author":"T Sterling","year":"2015","unstructured":"Sterling T, Irwin JJ (2015) ZINC 15\u2014ligand discovery for everyone. J Chem Inf Model 55:2324\u20132337","journal-title":"J Chem Inf Model"},{"key":"3838_CR45","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1093\/bioinformatics\/btl150","volume":"22","author":"K Stierand","year":"2006","unstructured":"Stierand K, MAA\u00df PC, Rarey M (2006) Molecular complexes at a glance: automated generation of two-dimensional complex diagrams. Bioinformatics 22:1710\u20131716","journal-title":"Bioinformatics"},{"key":"3838_CR46","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DEV Pires","year":"2015","unstructured":"Pires DEV, Blundell TL, Ascher DB (2015) pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem 58:4066\u20134072","journal-title":"J Med Chem"},{"key":"3838_CR47","first-page":"1355","volume":"60","author":"AW Schu\u00c8ttelkopf","year":"2004","unstructured":"Schu\u00c8ttelkopf AW, Van Aalten DM (2004) PRODRG: a tool for high-throughput crystallography of protein\u2013ligand complexes. Acta Crystallogr 60:1355\u20131363","journal-title":"Acta Crystallogr"},{"key":"3838_CR48","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1002\/jcc.20090","volume":"25","author":"C Oostenbrink","year":"2004","unstructured":"Oostenbrink C, Villa A, Mark AE, Gunsteren WFV (2004) A biomolecular force field based on the free enthalpy of hydration and solvation: the GROMOS force-field parameter sets 53A5 and 53A6. J Comput Chem 25:1656\u20131676","journal-title":"J Comput Chem"},{"key":"3838_CR49","doi-asserted-by":"publisher","first-page":"6269","DOI":"10.1021\/j100308a038","volume":"91","author":"HJC Berendsen","year":"1987","unstructured":"Berendsen HJC, Grigera JR, Straatsma TP (1987) The missing term in effective pair potentials. J Phys Chem 91:6269\u20136271","journal-title":"J Phys Chem"},{"key":"3838_CR50","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.bmc.2013.11.010","volume":"22","author":"M Ferrer-Casal","year":"2014","unstructured":"Ferrer-Casal M, Galizzi M, Stortz CA, Szajnman SH, Docampo R, Moreno SN, Rodriguez JB (2014) New insights into molecular recognition of 1,1-bisphosphonic acids by farnesyl diphosphate synthase. Bioorg Med Chem 22:398\u2013405","journal-title":"Bioorg Med Chem"},{"key":"3838_CR51","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.bbagen.2013.11.006","volume":"1840","author":"J Liu","year":"2014","unstructured":"Liu J, Liu W, Ge H, Gao H, He Q, Su L, Xu J, Gu L, Huang Z, Li D (2014) Syntheses and characterization of non-bisphosphonate quinolone derivatives as new FPPS inhibitors. Biochim Biophys Acta 1840:1051\u20131062","journal-title":"Biochim Biophys Acta"},{"key":"3838_CR52","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1517\/13543776.2011.593511","volume":"21","author":"S Sun","year":"2011","unstructured":"Sun S, McKenna CE (2011) Farnesyl pyrophosphate synthase modulators: a patent review (2006\u20132010). Expert Opin Ther Pat 21:1433\u20131451","journal-title":"Expert Opin Ther Pat"},{"key":"3838_CR53","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1517\/17460441.2016.1143814","volume":"11","author":"JB Rodriguez","year":"2016","unstructured":"Rodriguez JB, Falcone BN, Szajnman SH (2016) Approaches for designing new potent inhibitors of farnesyl pyrophosphate synthase. Expert Opin Drug Discovery 11:307\u2013320","journal-title":"Expert Opin Drug Discovery"},{"key":"3838_CR54","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s10822-008-9227-2","volume":"23","author":"RD Clark","year":"2009","unstructured":"Clark RD, Abrahamian \u00c6E (2009) Using a staged multi-objective optimization approach to find selective pharmacophore models. J Comput Aided Mol Des 23:765\u2013771","journal-title":"J Comput Aided Mol Des"},{"key":"3838_CR55","first-page":"1398","volume":"7","author":"M Liu","year":"2012","unstructured":"Liu M, Sun Z, Hu W (2012) Three-dimensional pharmacophore screening for fentanyl derivatives. Neural Regen Res 7:1398\u20131405","journal-title":"Neural Regen Res"},{"key":"3838_CR56","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10822-006-9082-y","volume":"20","author":"NJ Richmond","year":"2006","unstructured":"Richmond NJ, Abrams CA, Wolohan PR, Abrahamian E, Willett P, Clark RD (2006) GALAHAD\u00a0: 1. Pharmacophore identification y hypermolecular alignment of ligands in 3D. J Comput Aided Mol Des 20:567\u2013587","journal-title":"J Comput Aided Mol Des"},{"key":"3838_CR57","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/minf.201000061","volume":"29","author":"A Tropsha","year":"2010","unstructured":"Tropsha A (2010) Best practices for QSAR model development, validation, and exploitation. Mol Inf 29:476\u2013488","journal-title":"Mol Inf"},{"key":"3838_CR58","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jmgm.2010.08.005","volume":"29","author":"J Caballero","year":"2010","unstructured":"Caballero J (2010) 3D-QSAR (CoMFA and CoMSIA) and pharmacophore (GALAHAD) studies on the differential inhibition of aldose reductase by flavonoid compounds. J Mol Graph Model 29:363\u2013371","journal-title":"J Mol Graph Model"},{"key":"3838_CR59","doi-asserted-by":"publisher","first-page":"6147","DOI":"10.1016\/j.ejmech.2010.09.012","volume":"45","author":"P Athri","year":"2010","unstructured":"Athri P, Wenzler T, Tidwell R, Bakunova SM, Wilson WD (2010) Pharmacophore model for pentamidine analogs active against plasmodium falciparum. Eur J Med Chem 45:6147\u20136151","journal-title":"Eur J Med Chem"},{"key":"3838_CR60","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s10822-006-9070-2","volume":"20","author":"JK Shepphird","year":"2006","unstructured":"Shepphird JK, Clark \u00c6RD (2006) A marriage made in torsional space\u00a0: using GALAHAD models to drive pharmacophore multiplet searches. J Comput Aided Mol Des 20:763\u2013771","journal-title":"J Comput Aided Mol Des"},{"key":"3838_CR61","doi-asserted-by":"publisher","DOI":"10.1002\/3527609164","volume-title":"Pharmacophores and pharmacophore searches","author":"T Langer","year":"2006","unstructured":"Langer T, Hoffman RD (2006) Pharmacophores and pharmacophore searches. Wiley, Weinheim"},{"key":"3838_CR62","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.icvts.2004.01.008","volume":"3","author":"G Vanagas","year":"2004","unstructured":"Vanagas G (2004) Receiver operating characteristic curves and comparison of cardiac surgery risk stratification systems. Interact Cardiovasc Thorac Surg 3:319\u2013322","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"3838_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1568026611313090010","volume":"13","author":"RC Braga","year":"2013","unstructured":"Braga RC, Andrade CH (2013) Assessing the performance of 3D pharmacophore models in virtual screening: how good are they? Curr Top Med Chem 13:1\u201312","journal-title":"Curr Top Med Chem"},{"key":"3838_CR64","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1021\/ci600426e","volume":"48","author":"J Truchon","year":"2007","unstructured":"Truchon J, Bayly CI (2007) Evaluating virtual screening methods: good and bad metrics for the \u201cearly recognition\u201d problem. J Chem Inf Model 48:488\u2013508","journal-title":"J Chem Inf Model"},{"key":"3838_CR65","unstructured":"Domingues BF (2013) 3D-Pharma: Uma Ferramenta para Triagem Virtual Baseada em Fingerprints de Farmac\u00f3foros. Thesis, Universidade Federal de Minas Gerais"},{"key":"3838_CR66","doi-asserted-by":"publisher","first-page":"17075","DOI":"10.1074\/jbc.M210467200","volume":"278","author":"A Montalvetti","year":"2003","unstructured":"Montalvetti A, Fernandez A, Sanders JM, Ghosh S, Brussel EV, Oldfield E, Docampo R (2003) Farnesyl pyrophosphate synthase is an essential enzyme in Trypanosoma brucei. J Biol Chem 278:17075\u201317083","journal-title":"J Biol Chem"},{"key":"3838_CR67","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/8756-3282(95)00445-9","volume":"18","author":"JH Lin","year":"1996","unstructured":"Lin JH (1996) Bisphosphonates: a review of their pharmacokinetic properties. Bone 18:75\u201385","journal-title":"Bone"},{"key":"3838_CR68","doi-asserted-by":"publisher","first-page":"739","DOI":"10.5935\/1984-6835.20120055","volume":"4","author":"RP Rodrigues","year":"2012","unstructured":"Rodrigues RP, Mantoani SP, Almeida JR, Pinsetta FR, Semighini EP, Silva VB, Silva CHP (2012) Estrat\u00e9gias de triagem virtual no planejamento de f\u00e1rmacos. Rev Virtual Quim 4:739\u2013776","journal-title":"Rev Virtual Quim"},{"key":"3838_CR69","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ymeth.2014.07.007","volume":"71","author":"A Kumar","year":"2015","unstructured":"Kumar A, Zhang KYJ (2015) Hierarchical virtual screening approaches in small molecule drug discovery. Methods 71:26\u201327","journal-title":"Methods"},{"key":"3838_CR70","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s10822-012-9565-y","volume":"26","author":"SR Brozell","year":"2012","unstructured":"Brozell SR, Mukherjee S, Balius TE, Roe DR, Case DA, Rizzo RC (2012) Evaluation of DOCK 6 as a pose generation and database enrichment tool. J Comput Aided Mol Des 26:749\u2013773","journal-title":"J Comput Aided Mol Des"},{"key":"3838_CR71","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1021\/np070002y","volume":"71","author":"J Larsson","year":"2007","unstructured":"Larsson J, Gottfries J, Muresan S, Backlund A (2007) ChemGPS-NP: tuned for navigation in biologically relevant chemical space. J Nat Prod 71:789\u2013794","journal-title":"J Nat Prod"},{"key":"3838_CR72","first-page":"802","volume":"D70","author":"S Aripirala","year":"2014","unstructured":"Aripirala S, Gonzalez-Pacanowsk D, Oldfield E, Kaiser M, Amzele M, Gabelli SB (2014) Structural and thermodynamic basis of the inhibition of Leishmania major farnesyl diphosphate synthase by nitrogen-containing bisphosphonates. Acta Crystallogr D70:802\u2013810","journal-title":"Acta Crystallogr"},{"key":"3838_CR73","doi-asserted-by":"publisher","first-page":"9325","DOI":"10.4238\/2015.August.10.13","volume":"14","author":"YY Zhang","year":"2015","unstructured":"Zhang YY, Yang LQ, Guo LM (2015) Effect of phosphatidylserine on memory in patients and rats with Alzheimer\u2019s disease. Genet Mol Res 14:9325\u20139333","journal-title":"Genet Mol Res"},{"key":"3838_CR74","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.2174\/1871527313666141023144523","volume":"13","author":"I Sohail","year":"2014","unstructured":"Sohail I, Rashid S (2014) Molecular dynamics and regulation of Butyrylcholinesterase cholinergic activity by RNA binding proteins. CNS Neurol Disord Drug Targets 13:1366\u20131377","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"3838_CR75","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"23","author":"C Lipinski","year":"1997","unstructured":"Lipinski C, Lombardo F, Dominy B, Feeney P (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23:3\u201325","journal-title":"Adv Drug Deliv Rev"},{"key":"3838_CR76","unstructured":"Barbosa TGB (2010) An\u00e1lise computacional da influ\u00eancia da muta\u00e7\u00e3o M36I na intera\u00e7\u00e3o da protease do HIV-1 com seus substratos naturais. Graduation work, Universiade Federal do Rio de Janeiro"},{"key":"3838_CR77","unstructured":"Leite FHA (2015) Planejamento e avalia\u00e7\u00e3o de novos inibidores de pteridina redutase 1 (PTR1) de Leishmania major. Thesis, Universidade Federal da Bahia"},{"key":"3838_CR78","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jmgm.2006.02.001","volume":"25","author":"L Sigman","year":"2006","unstructured":"Sigman L, S\u00e1nchez VM, Turjanski AG (2006) Characterization of the farnesyl pyrophosphate synthase of Trypanosoma cruzi by homology modeling and molecular dynamics. J Mol Graph Model 25:345\u2013352","journal-title":"J Mol Graph Model"},{"key":"3838_CR79","unstructured":"SYBYL-X 2.0 (2012) Discovery Software for Computational Chemistry and Molecular Modelling, version 2.0. TriposInc, St. Louis, MO"}],"container-title":["Journal of Molecular Modeling"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00894-018-3838-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-018-3838-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-018-3838-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T11:22:21Z","timestamp":1720696941000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00894-018-3838-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,16]]},"references-count":79,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["3838"],"URL":"https:\/\/doi.org\/10.1007\/s00894-018-3838-x","relation":{},"ISSN":["1610-2940","0948-5023"],"issn-type":[{"value":"1610-2940","type":"print"},{"value":"0948-5023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,16]]},"assertion":[{"value":"13 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there were no conflicts of interest in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"314"}}